Cumulative corticosteroid exposure ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 49 | Systemic lupus erythematosus | 1 |
49. Systemic lupus erythematosus
Clinical trials : 993 / Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01616472 (ClinicalTrials.gov) | April 2012 | 7/6/2012 | WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) | WEUKBRE5716: Quantifying the Burden of Steroid-related Damage in Systemic Lupus Erythematosus in the Hopkins Lupus Cohort | Systemic Lupus Erythematosus | Drug: Cumulative corticosteroid exposure | GlaxoSmithKline | NULL | Completed | N/A | N/A | Both | 1 | N/A | NULL |